DELRAY BEACH, Fla., Aug. 8, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that it has appointed Pietro Galassetti, MD, PhD, to its Scientific Advisory Board. Dr. Galassetti is Associate Professor of Pediatrics and Pharmacology at the University of California, Irvine ("UCI"), where he also serves as the Director of the Bionutrition/Metabolism Core at the Institute for Clinical and Translational Science, and as Associate Director of the Pediatric Exercise Research Center. In his role as scientific advisor to PositiveID, Galassetti will contribute his expertise on breath analysis to the development of the Company's Easy Check™ non-invasive breath glucose detection device.
